Pronethalol

Pronethalol, sold under the brand name Alderlin, was an early non-selective beta blocker.

Uses your system voice; voice and rate in settings.

≈ 1 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Pronethalol, sold under the brand name Alderlin, was an early non-selective beta blocker. It was the first beta blocker to be developed by James Black and associates at Imperial Chemical Industries, and the first to enter clinical use, in November 1963.

However, it was never used widely due to carcinogenicity in mice, which was thought to result from formation of a carcinogenic naphthalene epoxide metabolite, and was superseded by propranolol from 1965 onward.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1366469266 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001366469266 · captured 2026-07-28 · ledger · version history

Cite this page as: encyclopegia.org, “Pronethalol”, snapshot enwiki-001366469266. https://encyclopegia.org/a/pronethalol

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.